e Laboratories (US:CLB)2026-02-04 21:58Financial Performance - Fourth quarter 2025 revenue was $138.3 million, up 3% sequentially and up 7% year-over-year[2]. - Fourth quarter operating income was $15.8 million, with operating margins of over 11%, down 100 basis points sequentially and 80 basis points year-over-year[3]. - Full year 2025 revenue was $526.5 million, slightly up from 2024, with full year EPS, ex-items, of $0.75, down 14%[3]. - The Company reported Q4 2025 revenue of $138,255,000, representing a 2.8% increase from Q3 2025 and a 7.0% increase from Q4 2024[33]. - Operating income for Q4 2025 was $15,832,000, down 24.4% from Q3 2025 but up 11.7% from Q4 2024[33]. - Net income attributable to Core Laboratories Inc. for Q4 2025 was $7,082,000, a decrease of 50.3% compared to Q3 2025 and a decrease of 4.3% compared to Q4 2024[33]. - For the full year 2025, total revenue was $526,520,000, a slight increase of 0.5% from $523,848,000 in 2024[35]. - The Company’s operating income for the year ended December 31, 2025, was $56,468,000, down 3.6% from $58,556,000 in 2024[35]. - Net income for the year ended December 31, 2025, was $32,525,000, an increase from $32,153,000 in 2024, representing a growth of 1.16%[39]. - The company reported a diluted earnings per share of $0.68 for the year ended December 31, 2025, consistent with the previous year[45]. Cash Flow and Debt Management - Free cash flow for the fourth quarter was $5.1 million, with full year free cash flow totaling $26.0 million[3][11]. - Net debt was reduced by $1.2 million in the fourth quarter, improving the leverage ratio to 1.09, the lowest level in nine years[3][15]. - Net cash provided by operating activities decreased to $37,176,000 in 2025 from $56,388,000 in 2024, a decline of 34.0%[39]. - Free cash flow for the year ended December 31, 2025, was $25,967,000, compared to $37,176,000 in operating cash flow after capital expenditures of $11,209,000[54]. - The company repaid $63,000,000 in long-term debt during 2025, compared to $82,000,000 in 2024, indicating a reduction in debt repayment[39]. - Long-term debt, net, decreased to $110,255,000 as of December 31, 2025, down 3.4% from $114,103,000 in Q3 2025[37]. - The cash and cash equivalents at the end of 2025 were $22,847,000, an increase from $19,157,000 at the end of 2024[39]. Segment Performance - Reservoir Description segment revenue for Q4 2025 was $92.3 million, up 5% sequentially and over 6% year-over-year, with operating margins of 14%[5]. - Production Enhancement segment revenue for Q4 2025 was $46.0 million, up over 8% year-over-year, with operating margins, ex-items, of 7%[8]. - The company anticipates first quarter 2026 revenue for Reservoir Description to range from $82 million to $86 million[25]. Future Guidance - First quarter 2026 revenue is projected to range from $124 million to $130 million, with EPS expected to be $0.11 to $0.15[26]. - The Company’s first quarter 2026 guidance includes an effective tax rate of 25% and reflects a higher interest rate due to a term loan of $50,000,000[27]. Tax and Capital Expenditures - The effective tax rate for Q4 2025 was 45%, significantly higher than 21% in Q3 2025 and 35% in Q4 2024[33]. - Capital expenditures for operations in 2025 totaled $11,209,000, slightly down from $11,888,000 in 2024[39]. Return on Investment - The return on invested capital (ROIC) was reported at 9.7%, calculated from a net operating profit after tax (NOPAT) of $38.8 million against an average total invested capital of $398.5 million[51]. Acquisitions - Core Lab completed the acquisition of Brazilian-based Solintec for approximately $2.3 million[13].